Long-term survival and safety of elranatamab in patients with relapsed or refractory multiple myeloma: Update from the MagnetisMM-3 study

Michael H. Tomasson; Shinsuke Iida; Ruben Niesvizky; Mohamad Mohty; Nizar J. Bahlis; Joaquin Martinez-Lopez; Guenther Koehne; Paula Rodriguez-Otero; H. Miles Prince; Andrea Viqueira; Eric Leip; Umberto Conte; Sharon T. Sullivan; Alexander M. Lesokhin

doi:10.1002/hem3.136

Long-term survival and safety of elranatamab in patients with relapsed or refractory multiple myeloma: Update from the MagnetisMM-3 study

Michael H. Tomasson
, Shinsuke Iida
, Ruben Niesvizky
, Mohamad Mohty
, Nizar J. Bahlis
, Joaquin Martinez-Lopez
, Guenther Koehne
, Paula Rodriguez-Otero
, H. Miles Prince
, Andrea Viqueira
, Eric Leip
, Umberto Conte
, Sharon T. Sullivan
, Alexander M. Lesokhin

Research output: Contribution to journal › Letter › peer-review

Original language	English
Article number	e136
Journal	HemaSphere
Volume	8
Issue number	7
DOIs	https://doi.org/10.1002/hem3.136
State	Published - Jul 2024
Externally published	Yes

ASJC Scopus Subject Areas

Hematology

Access to Document

10.1002/hem3.136

Cite this

Tomasson, M. H., Iida, S., Niesvizky, R., Mohty, M., Bahlis, N. J., Martinez-Lopez, J., Koehne, G., Rodriguez-Otero, P., Miles Prince, H., Viqueira, A., Leip, E., Conte, U., Sullivan, S. T., & Lesokhin, A. M. (2024). Long-term survival and safety of elranatamab in patients with relapsed or refractory multiple myeloma: Update from the MagnetisMM-3 study. HemaSphere, 8(7), Article e136. https://doi.org/10.1002/hem3.136

Tomasson, MH, Iida, S, Niesvizky, R, Mohty, M, Bahlis, NJ, Martinez-Lopez, J, Koehne, G, Rodriguez-Otero, P, Miles Prince, H, Viqueira, A, Leip, E, Conte, U, Sullivan, ST & Lesokhin, AM 2024, 'Long-term survival and safety of elranatamab in patients with relapsed or refractory multiple myeloma: Update from the MagnetisMM-3 study', HemaSphere, vol. 8, no. 7, e136. https://doi.org/10.1002/hem3.136

@article{73647e4761fe4d48959a83fe83aa3515,

title = "Long-term survival and safety of elranatamab in patients with relapsed or refractory multiple myeloma: Update from the MagnetisMM-3 study",

author = "Tomasson, \{Michael H.\} and Shinsuke Iida and Ruben Niesvizky and Mohamad Mohty and Bahlis, \{Nizar J.\} and Joaquin Martinez-Lopez and Guenther Koehne and Paula Rodriguez-Otero and \{Miles Prince\}, H. and Andrea Viqueira and Eric Leip and Umberto Conte and Sullivan, \{Sharon T.\} and Lesokhin, \{Alexander M.\}",

year = "2024",

month = jul,

doi = "10.1002/hem3.136",

language = "English",

volume = "8",

journal = "HemaSphere",

issn = "2572-9241",

number = "7",

}

TY - JOUR

T1 - Long-term survival and safety of elranatamab in patients with relapsed or refractory multiple myeloma

T2 - Update from the MagnetisMM-3 study

AU - Tomasson, Michael H.

AU - Iida, Shinsuke

AU - Niesvizky, Ruben

AU - Mohty, Mohamad

AU - Bahlis, Nizar J.

AU - Martinez-Lopez, Joaquin

AU - Koehne, Guenther

AU - Rodriguez-Otero, Paula

AU - Miles Prince, H.

AU - Viqueira, Andrea

AU - Leip, Eric

AU - Conte, Umberto

AU - Sullivan, Sharon T.

AU - Lesokhin, Alexander M.

PY - 2024/7

Y1 - 2024/7

UR - https://www.scopus.com/pages/publications/85199443925

UR - https://www.scopus.com/pages/publications/85199443925#tab=citedBy

U2 - 10.1002/hem3.136

DO - 10.1002/hem3.136

M3 - Letter

C2 - 39055646

AN - SCOPUS:85199443925

SN - 2572-9241

VL - 8

JO - HemaSphere

JF - HemaSphere

IS - 7

M1 - e136

ER -

Long-term survival and safety of elranatamab in patients with relapsed or refractory multiple myeloma: Update from the MagnetisMM-3 study

ASJC Scopus Subject Areas

Access to Document

Other files and links

Cite this